| Formulary Chapter 26: A5 - Wound managment products and elasticated garments - Full Chapter
|
| A5.08.03 |
Tubular bandages and garments |
|
|
Acti-Fast® 2-way stretch
(Viscose stockinette)
|
Formulary
|
Must be ordered on ONPOS, in line with OCCG Wound Management Formulary.
NB. Elasticated viscose stockinette for securing dressings in place when adhesive dressing or tape is not clinically indicated. For more information, please see Guidance for Selecting Alternatives to Foams.
APCO May 2015.
|
Comfigrip®
(Tubular bandage)
|
Formulary
|
Must be ordered on ONPOS, in line with OCCG Wound Management Formulary.
NB. Size D, E, F and G - all 1 meter lengths. For more information, please see Guidance for Selecting Alternatives to Foams.
APCO May 2015.
|
Comfinette®
(Viscose stockinette)
|
Formulary
|
Must be ordered on ONPOS, in line with OCCG Wound Management Formulary.
NB. Size 56 and 78 used as a liner under sub bandage wool if the patient has eczema or irritant dermatitis or a known sensitivity to wool. For more information, please see Guidance for Selecting Alternatives to Foams.
APCO May 2015.
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Red: Medicines which should only be prescribed in secondary care by a specialist. |
|
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred. |
|
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO). |
|
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care. |
|
Brown: Medicines which should only be prescribed in restricted circumstances. |
|
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety. |
|
not used |
|
|
